Clinical trials sponsored by University Hospital Schleswig-Holstein

Phase breakdown

Conditions studied

Recruiting trials led by University Hospital Schleswig-Holstein

• Dermatitis During Adjuvant Irradiation for BREAst Cancer:
  NCT06483477 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 5 locations
• Determinants of Chronic Inflammatory Skin Disease Trajectories
  NCT05928169 · Phase: Not specified · Ages: 0 Years to 80 Years · Sex: All (male and female) · 2 locations
• Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis
  NCT03361215 · Phase: Not specified · Ages: 0 Years to 100 Years · Sex: All (male and female) · 2 locations
• Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients With Mild to Moderately Active Ulcerative Colitis
  NCT06488625 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 26 locations
• Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed Moderate-to-severe Ulcerative Colitis
  NCT07235904 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III)
  NCT06914544 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 6 locations
• Influence of Glucose on Metabolism and Clinical Symptoms of Patients With Parkinson's Disease
  NCT05998772 · Phase: Not specified · Ages: 50 Years to 80 Years · Sex: All (male and female) · 1 location
• Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact
  NCT07444801 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia
  NCT07151339 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 1 location
• Prodromal Alpha-Synuclein Screening in Parkinson's Disease Study
  NCT04724941 · Phase: Not specified · Ages: 50 Years to 99 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is University Hospital Schleswig-Holstein recruiting for?

University Hospital Schleswig-Holstein is the lead sponsor of 10 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.